US7465574B2
(en)
*
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
US20030054505A1
(en)
*
|
1997-09-26 |
2003-03-20 |
Hong Jin |
Recombinant rsv expression systems and vaccines
|
US7846455B2
(en)
|
1996-07-15 |
2010-12-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated chimeric respiratory syncytial virus
|
US20050287540A1
(en)
*
|
1995-09-27 |
2005-12-29 |
Murphy Brian R |
Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
|
US7485440B2
(en)
|
1995-09-27 |
2009-02-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
|
US6689367B1
(en)
|
1995-09-27 |
2004-02-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
|
US6699476B1
(en)
|
1996-07-15 |
2004-03-02 |
Peter L. Collins |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
|
WO1998002530A1
(en)
*
|
1996-07-15 |
1998-01-22 |
The Government Of The United States Of America, As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
JP4198195B2
(ja)
*
|
1997-05-02 |
2008-12-17 |
ザ ユーエイビー リサーチ ファンデイション |
負鎖rnaウイルスの、それらの遺伝子の再配列による弱毒化およびそれらの使用
|
US6596529B1
(en)
*
|
1997-05-02 |
2003-07-22 |
Uab Research Foundation |
Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof
|
US7314631B1
(en)
|
1997-05-23 |
2008-01-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)
|
US7951383B2
(en)
|
1997-05-23 |
2011-05-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated parainfluenza virus (PIV) vaccines
|
US6410023B1
(en)
|
1997-05-23 |
2002-06-25 |
United States Of America |
Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
|
US7250171B1
(en)
|
1997-05-23 |
2007-07-31 |
United States Of America As Represented By The Dept. Of Health & Human Services |
Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein
|
US7192593B2
(en)
|
1997-05-23 |
2007-03-20 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
|
US7632508B2
(en)
|
1997-05-23 |
2009-12-15 |
The United States Of America |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
|
US20030082209A1
(en)
|
2000-07-05 |
2003-05-01 |
Skiadopoulos Mario H. |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
|
US7201907B1
(en)
|
1997-05-23 |
2007-04-10 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
|
CA2238659C
(en)
*
|
1997-05-26 |
2010-12-14 |
Akzo Nobel N.V. |
Recombinant birnavirus vaccine
|
FR2764903A1
(fr)
*
|
1997-06-23 |
1998-12-24 |
Pasteur Institut |
Detection des infections par des paramyxovirus (virus respiratoire syncitial et virus parainfluenza) utilisant des polynucleotides codant de la proteine l
|
US7662397B2
(en)
|
1997-07-15 |
2010-02-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
|
US20040005542A1
(en)
|
2001-06-22 |
2004-01-08 |
Krempl Christine D |
Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes
|
EP1015594A1
(de)
*
|
1997-09-19 |
2000-07-05 |
American Cyanamid Company |
Attenuierter respiratorischer synzytialvirus
|
US20100028377A1
(en)
*
|
1997-09-26 |
2010-02-04 |
Medimmune, Llc |
Recombinant RSV Virus Expression Systems And Vaccines
|
AU2006200619B2
(en)
*
|
1997-09-26 |
2007-12-13 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
US6830748B1
(en)
*
|
1997-09-26 |
2004-12-14 |
Medimmune Vaccines, Inc. |
Recombinant RSV virus expression systems and vaccines
|
US6908618B2
(en)
|
1997-11-10 |
2005-06-21 |
University Of Maryland |
Production of novel bovine respiratory syncytial viruses from cDNAs
|
DE69937999T2
(de)
|
1998-06-12 |
2009-01-29 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Interferon induzierende genetisch veränderte attenuierte viren
|
AU771110B2
(en)
|
1998-06-12 |
2004-03-11 |
Mount Sinai School Of Medicine Of The City University Of New York, The |
Novel methods and interferon deficient substrates for the propagation of viruses
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
US8715940B2
(en)
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
CA2369200A1
(en)
*
|
1999-04-13 |
2000-10-19 |
Peter L. Collins |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
|
BR0011159A
(pt)
*
|
1999-04-13 |
2002-07-23 |
Government Of The Us Dept Of H |
Método para produzir vacinas de vìrus rna de fita negativa atenuado a partir de sequências de nucleotìdeos clonados
|
US7820182B2
(en)
|
1999-07-09 |
2010-10-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
|
KR100940776B1
(ko)
|
1999-07-09 |
2010-02-11 |
더 가버먼트 오브 더 유나이티드 스테이츠 오브 어메리카 애즈 리프리젠티드 바이 더 디파트먼트 오브 헬스 앤 휴먼 서비씨즈 |
약독화된 사람-소 키메라 파라인플루엔자바이러스(piv) 백신
|
CN100354425C
(zh)
*
|
1999-07-09 |
2007-12-12 |
美国政府健康及人类服务部 |
减毒的人-牛嵌合呼吸道合胞病毒疫苗的生产
|
MXPA02000490A
(es)
*
|
1999-07-13 |
2004-09-27 |
Us Gov Health & Human Serv |
Produccion de virus sincitiales respiratorios recombinantes, que expresan moleculas inmunomoduladoras.
|
EP1211318B1
(de)
*
|
1999-09-06 |
2007-08-08 |
DNAVEC Research, Inc. |
Paramyxoviren, die eine modifizierte transkriptionsstartsequenz umfassen
|
US6764685B1
(en)
|
2000-03-21 |
2004-07-20 |
Medimmune Vaccines, Inc. |
Recombinant parainfluenza virus expression systems and vaccines
|
AU2001257001A1
(en)
|
2000-04-10 |
2001-10-23 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
DE10020505A1
(de)
*
|
2000-04-26 |
2001-10-31 |
Conzelmann Karl Klaus |
RSV NS Proteine antagonisieren die Interferon (IFN) Antwort
|
ES2330411T3
(es)
|
2000-06-23 |
2009-12-10 |
Intervet International Bv |
Virus sincitial respiratorio bovino atenuado.
|
ATE416251T1
(de)
*
|
2000-06-23 |
2008-12-15 |
Us Gov Health & Human Serv |
Respiratorische synzytialvirus impfstoffe, welche schützende antigene von promotor-proximalen genen exprimieren
|
WO2002030457A2
(en)
*
|
2000-10-12 |
2002-04-18 |
Washington University In St. Louis |
Microbes having an attenuating mutation comprising a transcription terminator
|
AU2002236522B2
(en)
*
|
2000-11-28 |
2007-10-25 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
US8715922B2
(en)
|
2001-01-19 |
2014-05-06 |
ViroNovative |
Virus causing respiratory tract illness in susceptible mammals
|
CN101921732A
(zh)
|
2001-01-19 |
2010-12-22 |
维洛诺瓦蒂夫公司 |
在易感哺乳动物中引起呼吸道疾病的病毒
|
UA82466C2
(uk)
*
|
2001-07-18 |
2008-04-25 |
Бавариан Нордика А/С |
Спосіб посилення ампліфікації хордопоксвірусу
|
WO2003029274A2
(en)
*
|
2001-09-28 |
2003-04-10 |
University Of North Carolina At Chapel Hill |
Paramyxoviruses as gene transfer vectors to lung cells
|
AU2002364121C1
(en)
|
2001-11-21 |
2010-02-18 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Recovery of recombinant human parainfluenza virus type 1 (HPIVI) from cDNA
|
IL163646A0
(en)
|
2002-02-21 |
2005-12-18 |
Vironovative Bv |
Recombinant parainfluenza virus expression systemsand vaccines comprising heterologous antigens derived from metapneumovirus
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
AU2003231083A1
(en)
|
2002-04-26 |
2003-11-10 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
WO2004027037A2
(en)
|
2002-09-18 |
2004-04-01 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
|
WO2004041838A1
(en)
*
|
2002-11-01 |
2004-05-21 |
University Of Massachusetts |
Regulation of transcription elongation factors
|
WO2005014626A2
(en)
*
|
2003-02-28 |
2005-02-17 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Recombinant human metapneumovirus and its use
|
US7704720B2
(en)
|
2003-04-25 |
2010-04-27 |
Medimmune, Llc |
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
|
EP1631663B1
(de)
|
2003-05-28 |
2016-08-24 |
Wisconsin Alumni Research Foundation |
Rekombinante influenza viren mit hohem titer zur impfung und gentherapie
|
CA2528002A1
(en)
|
2003-06-09 |
2004-12-29 |
Wyeth |
Improved method for the recovery of non-segmented, negative-stranded rna viruses from cdna
|
WO2005018539A2
(en)
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
DK1701738T3
(en)
*
|
2003-12-17 |
2015-03-30 |
Wyeth Llc |
Process for preparing storage-stable RSV compositions
|
DE602004027537D1
(de)
|
2003-12-23 |
2010-07-15 |
Medimmune Inc |
|
BRPI0418093A
(pt)
|
2003-12-24 |
2007-04-17 |
Nederlanden Staat |
vìrion de um pneumovìrus, método para produzir vìrions pneumovirais, composição, uso de um vìrion, e, método para a prevenção ou tratamento de uma infecção pneumoviral
|
CA2822895A1
(en)
|
2004-05-25 |
2005-12-08 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
CA2610632C
(en)
|
2004-06-01 |
2022-10-04 |
Mount Sinai School Of Medicine Of New York University |
Genetically engineered swine influenza virus and uses thereof
|
WO2006062701A2
(en)
*
|
2004-11-16 |
2006-06-15 |
Janssen Pharmaceutica N.V. |
Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene
|
MX2007005818A
(es)
|
2004-11-19 |
2007-07-20 |
Wisconsin Alumni Res Found |
Vectores recombinantes de la influenza con unidades de transcripcion en tandem.
|
EP1855713B1
(de)
|
2005-02-15 |
2016-04-27 |
Mount Sinai School of Medicine |
Gentechnisch hergestellter pferde-influenza-virus und seine verwendungen
|
ES2527503T3
(es)
|
2005-03-08 |
2015-01-26 |
Medimmune, Llc |
Virus influenza reordenantes
|
BRPI0612268A2
(pt)
|
2005-06-21 |
2009-01-27 |
Medimmune Vaccines Inc |
Ácido nucleico isolado, vetor de expressço, mÉtodos para produzir um rna genâmico da influenza, para produzir um vÍrus da influenza recombinante, para gerar um vÍrus de rna segmentado de filamento negativo recombinante nas cÉlulas caninas cultivadas e para gerar partÍculas virais da influenza infecciosa em cÉlulas caninas cultivadas, cÉlula, e, vÍrus
|
US7790434B2
(en)
|
2005-06-21 |
2010-09-07 |
Medimmune, Llc |
Methods and compositions for expressing negative-sense viral RNA in canine cells
|
AP2911A
(en)
|
2005-12-02 |
2014-05-31 |
Sinai School Medicine |
Chimeric Viruses presenting non-native surface proteins and uses thereof
|
AU2007245192B2
(en)
|
2006-03-31 |
2012-04-12 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
WO2008133701A1
(en)
|
2006-07-21 |
2008-11-06 |
Medimmune, Llc. |
Methods and compositions for increasing replication capacity of an influenza virus
|
CN104278014A
(zh)
|
2006-08-09 |
2015-01-14 |
米迪缪尼有限公司 |
流感血凝素和神经氨酸酶变体
|
EP4368202A2
(de)
|
2007-03-30 |
2024-05-15 |
The Research Foundation for The State University of New York |
Attenuierte viren für impfstoffe
|
WO2008156778A2
(en)
|
2007-06-18 |
2008-12-24 |
Tokiko Watanabe |
Influenza m2 protein mutant viruses as live influenza attenuated vaccines
|
EP2674486A1
(de)
|
2007-06-18 |
2013-12-18 |
MedImmune, LLC |
Influenza-B-Viren mit Veränderungen im Hämagglutininpolypeptid
|
EP2069485A4
(de)
*
|
2007-07-13 |
2011-05-25 |
Medimmune Llc |
Zubereitung von negativstrang-rna-viren mittels elektroporation
|
WO2010003032A2
(en)
*
|
2008-07-01 |
2010-01-07 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health A |
Recombinant human parainfluenza type 1 viruses (hpiv1s) containing mutations in or deletion of the c protein are attenuated in african green monkeys and in ciliated human airway epithelial cells and are potential vaccine candidates for hpiv1
|
CA2730408A1
(en)
|
2008-07-11 |
2010-01-14 |
Chin-Fen Yang |
Influenza hemagglutinin and neuraminidase variants
|
EP2343325A4
(de)
|
2008-11-05 |
2012-04-11 |
Asahi Glass Co Ltd |
Fluorhaltiges elastisches copolymer und herstellungsverfahren dafür sowie vernetztes kautschuk damit
|
EP2987856B1
(de)
|
2009-02-05 |
2018-07-25 |
Icahn School of Medicine at Mount Sinai |
Chimäre newcastle-krankheitsviren und verwendungen davon
|
EP2396033B1
(de)
|
2009-02-12 |
2016-09-28 |
MedImmune, LLC |
Influenza-hämagglutinin- und neuraminidase-varianten
|
CA2787099A1
(en)
|
2009-03-30 |
2010-10-14 |
Anice C. Lowen |
Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
|
WO2011014504A1
(en)
|
2009-07-27 |
2011-02-03 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza virus vectors and uses thereof
|
CA2805505C
(en)
|
2009-07-30 |
2021-08-03 |
Mount Sinai School Of Medecine |
Chimeric influenza viruses having reduced ability to reassort with other influenza viruses and uses thereof
|
WO2011056591A1
(en)
|
2009-10-26 |
2011-05-12 |
Warf - Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in vero cells
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
CA2792537A1
(en)
|
2010-03-30 |
2011-10-06 |
Mount Sinai School Of Medicine |
Influenza virus vaccines and uses thereof
|
US8597637B1
(en)
|
2010-05-18 |
2013-12-03 |
Weidong Zhang |
Breast cancer therapy using an engineered respiratory syncytial virus
|
US9044499B1
(en)
|
2010-06-22 |
2015-06-02 |
Weidong Zhang |
NS1/2-deficient respiratory syncytial virus and melanoma treatment
|
EP2758075B1
(de)
|
2011-09-20 |
2023-05-03 |
Icahn School of Medicine at Mount Sinai |
Influenzavirus-impfstoffe und verwendungen davon
|
ES2863477T3
(es)
*
|
2012-04-13 |
2021-10-11 |
Us Health |
Vacuna genéticamente estable viva atenuada contra el virus respiratorio sincitial y su producción
|
NZ627796A
(en)
|
2012-12-18 |
2017-07-28 |
Icahn School Med Mount Sinai |
Influenza virus vaccines and uses thereof
|
AU2014214763B2
(en)
|
2013-02-08 |
2020-02-27 |
The Research Foundation For The State University Of New York |
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
|
EP2970981B1
(de)
|
2013-03-14 |
2020-10-28 |
Emory University |
Rekombinante rsv mit stillen mutationen, impfstoffe und zugehörige verfahren
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
MX2015011886A
(es)
|
2013-03-14 |
2016-05-31 |
Icahn School Med Mount Sinai |
Virus de la enfermedad de newcastle y usos de los mismos.
|
EP3022296B1
(de)
|
2013-07-15 |
2022-12-28 |
Wisconsin Alumni Research Foundation |
Rekombinante influenzaviren mit hohem titer und erhöhter replikation in mdck- oder vero-zellen oder eiern
|
MX369469B
(es)
*
|
2013-08-21 |
2019-11-08 |
Curevac Ag |
Vacuna contra el virus respiratorio sincitial.
|
CN103789276B
(zh)
*
|
2014-01-14 |
2015-12-09 |
昆明理工大学 |
一种呼吸道合胞病毒减毒毒株及其应用
|
JP6857498B2
(ja)
|
2014-02-27 |
2021-04-14 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
癌を処置するための併用方法
|
CN106165542B
(zh)
*
|
2014-04-10 |
2018-08-07 |
株式会社日本有机雷特显示器 |
有机el显示面板的制造方法
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
CN107406835A
(zh)
|
2015-01-20 |
2017-11-28 |
***合众国,由健康及人类服务部部长代表 |
表达嵌合rsv/bpiv3f蛋白的重组人/牛副流感病毒3(b/hpiv3)及其用途
|
JP2018504412A
(ja)
|
2015-01-23 |
2018-02-15 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルスワクチン接種レジメン
|
EP3261664A1
(de)
|
2015-02-26 |
2018-01-03 |
Boehringer Ingelheim Vetmedica GmbH |
Bivalenter schweineinfluenzavirusimpfstoff
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
US9890363B2
(en)
|
2015-07-06 |
2018-02-13 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
MA42656A
(fr)
|
2015-08-20 |
2018-06-27 |
Univ Cornell |
Vaccin vivant atténué comprenant des mutations de polymérase virale pour le traitement et la prévention de virus de la grippe canine
|
WO2017031401A2
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Ns1 truncated virus for the development of canine influenza vaccines
|
WO2017031408A1
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Single-cycle virus for the development of canine influenza vaccines
|
BR112018008708A2
(pt)
|
2015-10-29 |
2018-11-06 |
Univ Emory |
rsv quimérico, composições imunogênicas e métodos de uso
|
JP2019510481A
(ja)
|
2016-02-19 |
2019-04-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ワクチン開発のための改善されたb型インフルエンザウイルス複製
|
MX2018014955A
(es)
|
2016-06-03 |
2019-05-13 |
Univ Rochester |
Vacunas atenuadas vivas del virus de la influenza equina.
|
US11266734B2
(en)
|
2016-06-15 |
2022-03-08 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus hemagglutinin proteins and uses thereof
|
WO2018057950A1
(en)
|
2016-09-23 |
2018-03-29 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Vaccine candidates for human respiratory syncytial virus (rsv) having attenuated phenotypes
|
WO2018187706A2
(en)
|
2017-04-07 |
2018-10-11 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza b virus neuraminidase antibodies and uses thereof
|
JOP20190256A1
(ar)
|
2017-05-12 |
2019-10-28 |
Icahn School Med Mount Sinai |
فيروسات داء نيوكاسل واستخداماتها
|
CN107384958B
(zh)
*
|
2017-07-14 |
2020-04-10 |
北京交通大学 |
基于反向遗传学构建的rsv反基因组质粒及其应用
|
EP3758748A1
(de)
|
2018-02-27 |
2021-01-06 |
University of Rochester |
Multivalenter abgeschwächter influenza-lebendimpfstoff zur vorbeugung und kontrolle des equinen influenzavirus (eiv) bei pferden
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
US11241492B2
(en)
|
2019-01-23 |
2022-02-08 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to genes in influenza viruses
|
US11851648B2
(en)
|
2019-02-08 |
2023-12-26 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
MX2021010343A
(es)
|
2019-02-27 |
2022-01-18 |
Univ Rochester |
Vacuna para la influenza multivalente con virus vivo atenuado para la prevencion y el control del virus de la influenza equina (eiv) en caballos.
|
US11390649B2
(en)
|
2019-05-01 |
2022-07-19 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
EP4022046A2
(de)
|
2019-08-27 |
2022-07-06 |
Wisconsin Alumni Research Foundation (WARF) |
Rekombinante influenzaviren mit stabilisiertem ha zur replikation in eiern
|